{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal Corlicyte",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "1. Number and percent of subjects who develop a high titer of antibodies to human leukocyte antigen (HLA) Class I molecules expressed on Corlicyte\u00ae",
                              "2. Time to development of high titer of antibodies to HLA Class I molecules expressed on Corlicyte\u00ae",
                              "3. Number and percent of subjects with an increase in ulcer size by the end of the Treatment Phase as reviewed by the Wound Core Laboratory (WCL).",
                              "4. Number and percent of subjects with an adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "5. Number and percent of subjects with a suspected adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "6. Number and percent of subjects with a suspected serious adverse reaction to Corlicyte\u00ae in each cohort and overall.",
                              "7. Change in hemoglobin A1c from Screening to End-of-Study/Early Termination"
                        ],
                        "SecondaryOutcomeMeasure": [
                              "Antibodies to HLA Class I - number and percent",
                              "Antibodies to HLA Class I - Time To Development",
                              "Increase Ulcer Size",
                              "Adverse Reaction",
                              "Suspected Adverse Reaction",
                              "Suspected Serious Adverse Reaction",
                              "Change in A1c"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject",
                              "throughout study completion, an average of 4 months per subject"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04104451"
                        ]
                  }
            ]
      }
}